Sphingosine kinase 1 overexpression contributes to sunitinib resistance in clear cell renal cell carcinoma
Sphingosine kinase 1 (SphK1) is the major source of the bioactive lipid and GPCR agonist sphingosine 1-phosphate (S1P). Although alterations in SphK1 expression and activity have been detected in various human malignancies, its potential molecular mechanisms in the development and sunitinib resistan...
| Autors principals: | , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Taylor & Francis Group
2018-12-01
|
| Col·lecció: | OncoImmunology |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/2162402X.2018.1502130 |